“In a drug target validation effort, Delta4 helped generate new insights regarding the clinical utility of a family of proteins. The Delta4 team members are highly competent in big data network analyses both from the disease side and from the drug product and pharmacology side. Their methodology of marrying one with the other led us to new intellectual property. In addition to their scientific strengths, the team also comes across as very forthcoming and adaptive to customer needs. Their reporting is thorough and to the point. We highly recommend Delta4 as an AI partner for drug discovery and development.”
– Johan Häggblad, PhD, Chief Scientific Officer at Calliditas Therapeutics.
At Delta4, we are leaders in all aspects of AI-enabled drug repurposing and indication expansion. We are committed to empowering scientists, clinicians, and drug developers to discover treatments for diseases, improve existing treatments, and make healthcare more efficient and effective for all. Our data-driven approach combines the power of Artificial Intelligence with the insights of experts in the field of drug repurposing to discover new uses and effectively expand indications for existing drugs.
Drug repurposing is the process of finding new therapeutic uses for existing drugs. This process can save companies time, money, and effort in the development of new treatments. The challenge, however, is that the process is complex and requires sophisticated algorithms to identify potential drug candidates.
Delta4 has invested heavily in developing Hyper-C, a comprehensive platform that enables drug discovery and repurposing. Our AI-enabled platform is designed to identify potential drug candidates and then rigorously assess their effectiveness.
We strive to provide our customers with the highest quality of service. We are constantly working to improve our platform and develop new algorithms that can uncover promising drug candidates faster and more accurately. We have a team of experienced professionals who are dedicated to helping our customers be successful in the drug repurposing process.
We believe that a comprehensive approach is the best way to uncover potential treatments. Our team is dedicated to leveraging cutting-edge computational drug repositioning approaches that can uncover novel treatments faster and more accurately than ever before. Delta4 employs more computational drug repositioning approaches than our competitors.
Scientist.com provides a unique platform where researchers and suppliers can both find each other and work together more easily. They provide a collaboration framework to streamline the typically long and tedious process of defining the terms and conditions of an agreement.
Members can work together smoothly and effortlessly by agreeing to the rules of the platform. The result is that together we can achieve the results we need faster.